Overall, these results show acquired resistance to inhibition of PD-L1 rewires the IFN-regulated secretory machinery in tumor cells, an effect that can be enhanced by IFN stimulation and include immune-modulating cellular ISG expression (Fig. 4K summary; Fig. EV3I shows statistics summary). The gene discussed is IFNA1; the disease is neoplasm.